Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models
Lisa Crawford(Queen's University Belfast), A E Irvine(Queen's University Belfast)
Cited by 26